# Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer

> **NCT00976365** · PHASE2 · COMPLETED · sponsor: **Taiwan THL Co.LTd.** · enrollment: 60 (estimated)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** THL-P

## Key facts

- **NCT ID:** NCT00976365
- **Lead sponsor:** Taiwan THL Co.LTd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-01
- **Final completion:** 2011-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976365, "Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00976365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*